Invictus Seeks to Commercialize NICU Active Noise Control Device
Invictus Medical has submitted a De Novo application to the FDA for its Neoasis incubator-based active noise control device.
Invictus Medical has submitted a De Novo application to the FDA for its Neoasis incubator-based active noise control device.
Several top chain restaurants in America do not have a policy of installing an automated external defibrillator at their businesses.
Hospitals in Tennessee are grappling with a shortage of staff and ECMO, or extracorporeal membrane oxygenation machines.
Invictus Medical has submitted a De Novo application to the FDA for its Neoasis incubator-based active noise control device.
Within eight weeks of starting its ‘Help India Defeat COVID-19’ campaign, Sewa International has distributed over 5,996 oxygen concentrators and 177 ventilators to 566 hospitals and COVID-19 care centers across India, covering 26 of 28 Indian states.
Read MoreMedtronic plc announces the U.S. commercial launch of the SonarMed pediatric airway monitoring system, which utilizes acoustic technology to check for endotracheal tube obstruction and verify position in real-time.
Read MoreWatertown, Mass.-based Respiratory Motion Inc., a manufacturer of noninvasive respiratory volume-monitoring technologies, announces the launch of the digital ExSpiron2Xi—its first product launch since 2017.
Read MoreMinneapolis-based Smiths Medical announces the launch of the Acapella choice blue vibratory positive expiratory pressure therapy system.
Read MoreSewa International is sending an initial shipment of 400 oxygen concentrators and other emergency medical devices and supplies to India immediately and is working on procuring more to ease the oxygen shortage caused by the surging numbers of COVID-19 cases in the country.
Read MoreLondon-based LivaNova PLC announces that it has received U.S. FDA 510(k) clearance for B- Capta, the in-line, blood-gas monitoring system integrated into the S5 heart-lung machine.
Read MoreMedtronic has received U.S. FDA approval for its Harmony Transcatheter Pulmonary Valve, the first minimally invasive therapy created to treat patients with a specific type of congenital heart defect of the right ventricle.